Home > Drug Search >
  • company_query: AlphaVax
  •   > 
Drug Filter
Category:
chemistry (7) biology (21)
Status:
Approved (1) NDA Filing (1) BLA Filing (2) Phase Ⅲ (6) Phase Ⅱ (14) Phase Ⅰ (4)
Clinical Stage:
Pending (3) Active (13) Discontinued (11)
Bio-Type:
Gene therapy (1) Oncolytic virus (1) Vaccine (17) Whole antibody (1) Fusion protein (1)
Indication:
Asthma (1) Atopic dermatitis (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Cutaneous T cell lymphoma (CTCL) (1) Deep vein thrombosis (DVT) (1) Eczema (1) Gastric cancer (1) HBV infection (1) Influenza virus infection (1) Melanoma (2) Metastatic breast cancer (1) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (1) Measles (1) Mumps (1) Rubella (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Solid tumours (3) Rotavirus infection (1) Ulcerative colitis (1) Urinary tract infections (1) Colorectal cancer (2) Yersinia pestis infection (1) Campylobacter infections (1) neurodermatitis (1) Skin pruritus (1) Stroke (1) Type 1 diabetes (1) Glioblastoma (1) Allergic asthma (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top